Characterization of a mobilization-competent simian immunodeficiency virus (SIV) vector containing a ribozyme against SIV polymerase

Journal of General Virology

Volumn 85, Issue 6, 2004, Pages 1489-1496

  Morris, Kevin V ^a   Grahn, Robert A ^b   Looney, David J ^a   Pedersen, Niels C ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; POL PROTEIN; PROTEIN P27; RETROVIRUS VECTOR; REV PROTEIN; RIBOZYME; RNA POLYMERASE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FEASIBILITY STUDY; GENETIC TRANSDUCTION; LONG TERMINAL REPEAT; MACACA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSACTIVATION; VIRAL GENE THERAPY; GENE THERAPY; GENE VECTOR; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR GENETICS; MONKEY DISEASE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENE PRODUCTS, POL; GENE THERAPY; GENETIC VECTORS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RNA, CATALYTIC; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 2942631183     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19106-0     Document Type: Article

References (42)

1. Akhtar, S., James, H. & Gibson, I. (1995). Molecular DIY with hairpins and hammerheads. Nat Med 1, 300-302.
2. Amarzguioui, M. & Prydz, H. (1998). Hammerhead ribozyme design and application. Cell Mol Life Sci 54, 1175-1202.
3. Aronoff, R. & Linial, M. (1991). Specificity of retroviral RNA packaging. J Virol 65, 71-80.
4. Arya, S. K. (1988). Human and simian immunodeficiency retroviruses: activation and differential transactivation of gene expression. AIDS Res Hum Retrovir 4, 175-186.
5. Barinaga, M. (1994). Steps taken toward improved vectors for gene therapy. Science 266, 1326.
6. + cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes. Blood 89, 2259-2267.
7. Buchschacher, G. L. & Wong-Staal, F. (2000). Development of lenti-viral vectors for gene therapy for human diseases. Blood 95, 2499-2504.
8. Bukovsky, A. A., Song, J. & Naldini, L. (1999). Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells. J Virol 73, 7987-7092.
9. Cech, T. R. (1987). The chemistry of self-splicing RNA and RNA enzymes. Science 236, 1532-1539.
10. Coffin, J. M. (1995). HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489.
11. Coffin, J. M. (1996). HIV viral dynamics. AIDS 10 (Suppl. 3), S75-84.
12. Corbeau, P. & Wong-Staal, F. (1998). Anti-HIV effects of HIV vectors. Virology 243, 268-274.
13. Desrosiers, R. C., Lifson, J. D., Gibbs, J. S., Czajak, S. C., Howe, A. Y. M., Arthur, L. O. & Johnson, R. P. (1998). identification of highly attenuated mutants of simian immunodeficiency virus. J Virol 72, 1431-1437.
14. Dropulic, B. M. H. & Pitha, P. M. (1996). A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread. Proc Natl Acad Sci U S A 93, 11103-11108.
15. Dropulic, B., Lin, N. H., Martin, M. A. & Jeang, K. (1992). Functional characterization of a U5 ribozyme: intracellular suppression of HIV-1 expression. J Virol 66, 1432-1441.
16. Evans, J. T. & Garcia, J. V. (2000). Lentivirus vector mobilization and spread by human immunodeficiency virus. Hum Gene Ther 11, 2331-2339.
17. Garzino-Demo, R. C. G. & Arya, S. K. (1995). Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element. Hum Gene Ther 2, 177-184.
18. Gazzard, B. (1999). The picture of future therapy. Int J Clin Pract (Suppl.) 103, 145-148.
19. Geigenmuller, U. & Linial, M. L. (1996). Specific binding of human immunodeficiency virus type 1 (HIV-1) Gag-derived proteins to a 5′ HIV-1 genomic RNA sequence. J Virol 70, 667-671.
20. Gibbs, J. S., Regier, D. A. & Desrosiers, R. C. (1994). Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes. AIDS Res Hum Retrovir 10, 607-616.
21. James, H. A. & Gibson, I. (1998). The therapeutic potential of ribozymes. Blood 91, 371-382.
22. Joshi, S., Shi-Fa, D. & Liam, S. E. (1997). Co-packaging of non-vector RNAs generates replication-defective retroviral vector particles: a novel approach for blocking retrovirus replication. Nucleic Acids Res 25, 3199-3204.
23. Kim, V. N., Mitrophanous, K., Kingsman, S. M. & Kingsman, A. J. (1998). Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol 72, 811-816.
24. Klimatcheva, E., Planelles, V., Day, S. L., Fulreader, F., Renda, M. J. & Rosenblatt, J. (2001). Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication. Mol Ther 3, 928-939.
25. Leavitt, M. C., Yu, M., Yamada, O., Kraus, G., Looney, D., Poeschla, E. & Wong-Staal, F. (1994). Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes. Hum Gene Ther 5, 1115-1120.
26. Lohman, B. L., Higgins, J., Marthas, M. L., Marx, P. A. & Pedersen, N. C. (1991). Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. J Clin Microbiol 29, 2187-2192.
27. Mangeot, P. E., Negre, D., Dubois, B., Winter, A. J., Leissner, P., Mehtali, M., Kaiserlian, D., Cosset, F. L. & Darlix, J. L. (2000). Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells. J Virol 74, 8307-8315.
28. Mangeot, P. E., Duperrier, K., Negre, D., Boson, B., Rigal, D., Cosset, F. L. & Darlix, J. L. (2002). High levels of transduction of human dendritic cells with optimized SIV vectors. Mol Ther 5, 283-290.
29. Marschall, P., Thomson, J. B. & Eckstein, F. (1994). Inhibition of gene expression with ribozymes. Cell Mol Neurobiol 14, 523-538.
30. Mautino, M. R. (2002). Lentiviral vectors for gene therapy of HIV-1 infection. Curr Gene Ther 2, 23-43.
31. Mautino, M. R., Keiser, N. & Morgan, R. A. (2001). Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev. J Virol 75, 3590-3599.
32. Miller, A. D. & Wolgamot, G. (1997). Murine retroviruses use at least six different receptors for entry into Mus dunni cells. J Virol 71, 4531-4535.
33. Milman, G. & Herzberg, M. (1981). Efficient DNA transfection and rapid assay for thymidine kinase activity and viral antigenic determinants. Somat Cell Genet 7, 161-170.
34. Naidu, Y. M., Kestler, H. W., Li, Y. & 8 other authors (1988). Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SlVmac. J Virol 62, 4691-4696.
35. Parolin, C., Taddeo, B., Palu, G. & Sodroski, J. (1996). Use of cis- and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes. Virology 222, 415-422.
36. Regier, D. A. & Desrosiers, R. C. (1990). The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retrovir 6, 1221-1231.
37. Rossi, J. (2000). Ribozyme therapy for HIV infection. Adv Drug Deliv Rev 44, 71-78.
38. Shafer, R. W. & Vuitton, D. A. (1999). Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. Biomed Pharmacother 53, 73-86.
39. Sykes, P. J., Neoh, S. H., Brisco, M. J., Hughes, E., Condon, J. & Morley, A. A. (1992). Quantitation of targets for PCR by use of limiting dilution. Biotechniques 13, 444-449.
40. Weinberger, L. S., Schaffer, D. V. & Arkin, A. P. (2003). Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection. J Virol 77, 10028-10036.
41. Wu, X., Wakefield, J. K., Liu, H. & Kappes, J. C. (2001). Analysis of lenti- and trans-lentiviral vector genetic recombination. Dev Biol 106, 237-248.
42. Yu, M., Leavitt, M. C., Maruyama, M., Yamada, O., Young, D., Ho, A. D. & Wong-Staal, F. (1995). Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 92, 699-703.